Article

Intracameral medication use requires careful consideration of pros and cons

When thinking about administering medications intracamerally during cataract surgery, it is important to consider whether their potential benefits are worth the risk, said Nick Mamalis, MD, at Spotlight on Cataracts 2007.

When thinking about administering medications intracamerally during cataract surgery, it is importantto consider whether their potential benefits are worth the risk, said Nick Mamalis, MD, at Spotlighton Cataracts 2007.

Intracameral medications may be used in cataract surgery for anesthesia, pupil dilation, and toprevent inflammation and endophthalmitis. Their advantages include ease of delivery, elimination oftoxicity of topical drops, avoidance of compliance issues, and possibly enhanced efficacy.

However, there are a number of downsides. Toxicity is an important risk that can occur throughmultiple mechanisms, which can be related to improper concentration, pH, or osmolarity. In addition,all medications used intracamerally should be preservative-free, but it is also important to be awareof toxicity related to stabilizing agents, such as are found in preservative-free epinephrine.Infectious contamination is another safety concern as is the potential for incompatibility whenmultiple drugs are combined.

"There are many trade-offs to consider when weighing the pros and cons of using topical drops versusintracameral medications. Intracameral medication safety can be improved if we could eliminate'kitchen pharmacy,'" Dr. Mamalis said.

"We need sterile, pre-mixed, preservative-free, unit-dose products, and the ophthalmology communityneeds to work with the FDA and industry to achieve that goal," he added.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.